{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T02:46:26Z","timestamp":1774233986401,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011471","name":"Shanghai Minhang Health And Family Planning Commission","doi-asserted-by":"publisher","award":["20184Y0199"],"award-info":[{"award-number":["20184Y0199"]}],"id":[{"id":"10.13039\/501100011471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cca.2020.12.014","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T01:16:18Z","timestamp":1608081378000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC"],"prefix":"10.1016","volume":"514","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-1709","authenticated-orcid":false,"given":"Weifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2384-3348","authenticated-orcid":false,"given":"Lixia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.12.014_b0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.12.014_b0010","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2020.12.014_b0015","article-title":"The disease burden and clinical characteristics of inflammatory bowel disease in the Chinese population: a systematic review and meta-analysis","volume":"14","author":"Li","year":"2017","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cca.2020.12.014_b0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrgastro.2016.128","article-title":"Current best practice for disease activity assessment in IBD","volume":"13","author":"Walsh","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2020.12.014_b0025","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/ibd.20920","article-title":"Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2020.12.014_b0030","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.3748\/wjg.v24.i33.3681","article-title":"From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting","volume":"24","author":"Mumolo","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2020.12.014_b0035","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2050640616686517","article-title":"Compliance with the faecal calprotectin test in patients with inflammatory bowel disease","volume":"5","author":"Marechal","year":"2017","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.cca.2020.12.014_b0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"10","author":"Vermeire","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2020.12.014_b0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2020.12.014_b0050","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3748\/wjg.v22.i3.1304","article-title":"Antibody markers in the diagnosis of inflammatory bowel disease","volume":"22","author":"Mitsuyama","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2020.12.014_b0055","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1572-0241.2004.40369.x","article-title":"Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype","volume":"99","author":"Zholudev","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.cca.2020.12.014_b0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","article-title":"Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis","volume":"159","author":"Torres","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2020.12.014_b0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0016-5085(81)90007-X","article-title":"Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing\/sodium dodecyl sulfate gel electrophoresis","volume":"80","author":"Scheele","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2020.12.014_b0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00364745","article-title":"The human C-reactive protein gene (CRP) and serum amyloid P component gene (APCS) are located on the proximal long arm of chromosome 1","volume":"24","author":"Floyd-Smith","year":"1986","journal-title":"Immunogenetics"},{"key":"10.1016\/j.cca.2020.12.014_b0075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF03401789","article-title":"Human serum amyloid P component is a single uncomplexed pentamer in whole serum","volume":"6","author":"Hutchinson","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.cca.2020.12.014_b0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/187152811796117744","article-title":"Pentraxins: CRP and PTX3 and cardiovascular disease","volume":"10","author":"Maekawa","year":"2011","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.cca.2020.12.014_b0085","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.ajpath.2019.08.005","article-title":"Serum amyloid P and a dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin ligand inhibit high-fat diet-induced adipose tissue and liver inflammation and steatosis in mice","volume":"189","author":"Pilling","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2020.12.014_b0090","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.pupt.2013.01.008","article-title":"Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis","volume":"26","author":"Dillingh","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2020.12.014_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009683","article-title":"Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages","volume":"5","author":"Murray","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2020.12.014_b0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11882-013-0377-5","article-title":"New approaches to modulating idiopathic pulmonary fibrosis","volume":"13","author":"Gomer","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.cca.2020.12.014_b0105","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.179.6.4035","article-title":"Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P","volume":"179","author":"Pilling","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2020.12.014_b0110","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2012-303955","article-title":"Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation","volume":"62","author":"Cader","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cca.2020.12.014_b0115","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2020.12.014_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ibd.20011","article-title":"Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?","volume":"13","author":"Ravi","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2020.12.014_b0125","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1021\/bi020582s","article-title":"Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen","volume":"42","author":"Moilanen","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2020.12.014_b0130","doi-asserted-by":"crossref","first-page":"14584","DOI":"10.1073\/pnas.97.26.14584","article-title":"Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen","volume":"97","author":"Noursadeghi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cca.2020.12.014_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin. J. Gastroenterol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:03:38Z","timestamp":1762113818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120305751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":27,"alternative-id":["S0009898120305751"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.12.014","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}